Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Tumors”

14,566 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,566 results

Not applicableActive Not RecruitingNCT05636592
What this trial is testing

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 250
Large-scale testing (Phase 3)Active Not RecruitingNCT04603807
What this trial is testing

Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 217
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)UnknownNCT03411967
What this trial is testing

Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

Who this might be right for
Lung Cancer
Zigong No.1 Peoples Hospital 20
Early research (Phase 1)Study completedNCT01957007
What this trial is testing

Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 34
Large-scale testing (Phase 3)Study completedNCT00775307
What this trial is testing

Adjuvant Pazopanib in Stage I NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07679607
What this trial is testing

GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the Lung

Who this might be right for
Lung Cancer (NSCLC)Radiation
University of Maryland, Baltimore 70
Not applicableUnknownNCT05771207
What this trial is testing

Effects of Protein on Muscle, Gut Microbiota and Clinical Outcome in Patients With Lung Cancer-related Sarcopenia

Who this might be right for
Lung CancerSarcopenia
Peking Union Medical College Hospital 90
Not applicableUnknownNCT06581107
What this trial is testing

Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Lung Cryablation Procedures

Who this might be right for
Lung CancerThoracic Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Large-scale testing (Phase 3)Study completedNCT01763671
What this trial is testing

Paclitaxel-bevacizumab in Advanced Lung Cancer

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648200
What this trial is testing

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive StageSmall Cell Lung Cancer Recurrent
Shanghai Pulmonary Hospital, Shanghai, China 100
Post-approval studies (Phase 4)UnknownNCT01926171
What this trial is testing

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small-cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 80
Not applicableLooking for participantsNCT05427136
What this trial is testing

Early Pulmonary Dysfunction in Childhood Cancer Patients

Who this might be right for
Pulmonary Dysfunction
University Children's Hospital Basel 140
Testing effectiveness (Phase 2)Study completedNCT03046992
What this trial is testing

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Who this might be right for
EGFR Gene Mutation
Yuhan Corporation 224
Testing effectiveness (Phase 2)Study completedNCT01204307
What this trial is testing

Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation

Who this might be right for
Advanced Non-Squamous Non-Small Cell Lung Cancer
Chang Gung Memorial Hospital 101
Not applicableLooking for participantsNCT06930807
What this trial is testing

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Who this might be right for
Non-small Cell Lung CancerMinimal Residual DiseaseAdaptive Treatment
Peking University People's Hospital 1,000
Not applicableUnknownNCT06270992
What this trial is testing

Oral Microbiome Diagnostics of Lung Cancer

Who this might be right for
Lung Cancer
TC Erciyes University 676
Early research (Phase 1)UnknownNCT03050411
What this trial is testing

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01610336
What this trial is testing

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 161
Next Page